Quantgene
Johannes Bhakdi is the CEO of Quantgene. Johannes holds a degree in Economics from University of Tübingen.
Quantgene
Medical technology now allows for cancer to be detected in a patient’s blood through cell-free DNA (cfDNA). Quantgene has developed a method for Deep Human Genome sequencing which allows us to see mutational patterns of disease down to a single molecule. This means diseases like cancer can be detected far earlier than ever before.